Core metabolic prognostic signatures are identified, comprising NUDT1 and GAPDH in kidney renal cell carcinoma and SQLE, ALG3 and PSPH in two independent breast carcinoma cohorts. This evidence concerns the gene PSPH and breast carcinoma.